Trials / Completed
CompletedNCT02717572
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In the current study, the investigators plan to expand the knowledge of Positron Emission Tomography/Magnetic Resonance (PET/MR) reliability by assessing the repeatability of fludeoxyglucose (FDG) standardized uptake values (SUV) measurements, as well as apparent diffusion coefficients (ADC) measurements, in a broad population of patients with malignant solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Fludeoxyglucose F 18 | |
| DEVICE | Positron Emission Tomography | |
| DEVICE | Computerized Tomography | |
| DEVICE | Magnetic Resonance Imaging |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-06-05
- Completion
- 2017-06-05
- First posted
- 2016-03-23
- Last updated
- 2019-04-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02717572. Inclusion in this directory is not an endorsement.